F. Pollarsky

IDENTIFICATION OF OPTIMAL THERAPEUTIC WINDOW FOR STEROID USE IN SEVERE ALCOHOL-ASSOCIATED HEPATITIS: A WORLDWIDE STUDY.

Muhammad Tariq Majeed, Douglas A. Simonetto, R. Bataller, 2021, Journal of hepatology.

Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy

H. Vázquez, P. Salgado, M. Marino, 2021, World journal of gastroenterology.

Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury

H. Vázquez, P. Salgado, D. Álvarez, 2020, Digestive Diseases and Sciences.

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis

P. Kamath, S. Sarin, R. Maiwall, 2023, JHEP reports : innovation in hepatology.

Baseline Severity and Inflammation Would Influence the Effect of Simvastatin on Clinical Outcomes in Cirrhosis Patients

H. Vázquez, P. Salgado, D. Álvarez, 2023, Digestive Diseases and Sciences.

Fibrosis assessment in patients with nonalcoholic fatty liver disease: Adherence to proposed algorithms and barriers to complying with them.

S. Marciano, B. Ríos, A. Gadano, 2021, Revista de gastroenterologia de Mexico.

Impact of acute-on-chronic liver failure on post-transplant survival and on kidney outcomes.

J. Ortiz, S. Marciano, D. Giunta, 2019, European journal of gastroenterology & hepatology.